Emilio Casanova
Has grant
Professor
Research Interests
Explore related searches
Contact this professor
About
Professor Emilio Casanova is a faculty member at Medizinische Universität Wien, Austria. His research areas include the immune response in cancer, specifically colorectal and lung cancers, as well as innovative treatment approaches for acute myeloid leukemia. Recent publications highlight his work on the role of TYK2 in immune surveillance and the implications of STAT3 in leukemia outcomes.
Recent Grants
Grant: Close
CarboLIB
Open Date: 2016-01-01
Close Date: 2019-01-01
Grant: Close
Humira antibody production
Open Date: 2016-01-01
Close Date: 2016-03-01
Grant: Close
European Aids Vaccine Initiative
Open Date: 2015-01-01
Close Date: 2020-01-01
Grant: Close
Development of BAC-based expression vectors applied to protein production in mammalian cells
Open Date: 2015-01-01
Close Date: 2015-12-01
Grant: Close
Production of Secretory IgA
Open Date: 2015-01-01
Close Date: 2018-12-01
Articles (18)
Defects in microvillus crosslinking sensitize to colitis and inflammatory bowel disease
Intestinal epithelial cells are covered by the brush border, which consists of densely packed microvilli. The Intermicrovillar Adhesion Complex (IMAC) links the microvilli and is required for proper brush border organization. Whether microvillus crosslinking is involved in the intestinal barrier function or colitis is currently unknown. We investigate the role of microvillus crosslinking in colitis in mice with deletion of the IMAC component CDHR5. Electron microscopy shows pronounced brush border defects in CDHR5‐deficient mice. The defects result in severe mucosal damage after exposure to the colitis‐inducing agent DSS. DSS increases the permeability of the mucus layer and brings bacteria in direct contact with the disorganized brush border of CDHR5‐deficient mice. This correlates with bacterial invasion into the epithelial cell layer which precedes epithelial apoptosis and inflammation. Single‐cell RNA sequencing data of patients with ulcerative colitis reveals downregulation of CDHR5 in enterocytes of diseased areas. Our results provide experimental evidence that a combination of microvillus crosslinking defects with increased permeability of the mucus layer sensitizes to inflammatory bowel disease.
Year:
2023
Collaborators (15)
Christiane Ferran
Lewis Thomas Professor of Surgery
Harvard University
Dietmar Herndler-Brandstetter
-
Kristina Breitenecker
Medical University of Vienna
Bjørn Gunnar Voldborg
Technical University of Denmark
Daniela Zwolanek
Medical University of Vienna
Mathias Müller
Full Professor / Head of Institute
University of Veterinary Medicine
Robert Eferl
-
Dana Krauß
Medical University of Vienna
Ion Cristian Cirstea
Ulm University
Sara Petersen Bjørn
Technical University of Denmark
Klaus Podar
Consultant/ Head Division Molecular Oncology and Hematology
Karl Landsteiner University of Health Sciences
Sophie Edtmayer
Karl Landsteiner University of Health Sciences
Heinz Sill
Medical University of Graz
Sascha Klee
Karl Landsteiner University of Health Sciences
Rainer Hahn
-

How do I reach out?
Sign in for free to see their profile details and contact information.